Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- ;
- Medical Research Council
- University of Exeter
- ; University of Surrey
- Cranfield University
- University of Bath
- ; Cranfield University
- ; Dublin City University
- ; MRC Laboratory of Molecular Biology
- CRANFIELD UNIVERSITY
- DURHAM UNIVERSITY
- Dublin City University
- Durham University
- European Magnetism Association EMA
- Lancaster University
- MRC Laboratory of Molecular Biology.
- NATA
- Nature Careers
- Trinity College Dublin
- University of Derby
- University of Oxford
- University of Ulster
- University of the West of England
- 13 more »
- « less
-
Field
-
and the UK Research and Innovation (UKRI). The post holder will work on the behavioural insights research stream, which is led by an interdisciplinary academic team, and the Northern Ireland Department
-
the European Union (Horizon Europe MSCA Doctoral Networks), whilst 1 Doctoral Candidate is funded by the UK Research and Innovation (UKRI) Horizon Europe guarantee scheme. The two main objectives of EU-GLOCTER are: (1
-
Candidates are funded by the European Union (Horizon Europe MSCA Doctoral Networks), whilst 1 Doctoral Candidate is funded by the UK Research and Innovation (UKRI) Horizon Europe guarantee scheme. The two main
-
Research and Innovation (UKRI) full-time home rate for PhD degrees. The UKRI Indicative Fee Level for 2024/25 is £4,786. An additional travel and related expenses grant will be provided courtesy
-
Policy Partnership (LPIP) hub, led by Ulster University and funded by the Economic and Social Research Council (ESRC), Arts and Humanities Research Council (AHRC), Innovate UK and the UK Research and
-
Sciences Research Council (BBSRC), which in turn are part of UK Research and Innovation (UKRI). Our activities are divided between our role as the UK’s major 3Rs research and innovation funder and programmes
-
Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund to establish a nucleic
-
Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund to establish a nucleic
-
Nucleic Acid Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund
-
resources. It is not an independent public body and for this reason it operates under the umbrella of the Medical Research Council (MRC), which is part of UK Research and Innovation (UKRI), using some UKRI